Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Chang Hak Sohn"'
Publikováno v:
LHI Journal of Land, Housing, and Urban Affairs. 2:569-575
In domestic mechanical demolition work against RC building, unsuitable selection and loading of heavy equipment have led to occasional accidents such as collapse of structural members during the work. Therefore, proper analysis technique to easily de
Publikováno v:
LHI Journal of Land, Housing, and Urban Affairs. 2:195-204
During mechanical demolition of RC structures, weights of dismantling equipment and demolition waste of building are applied to unexpected load which did not be considered during the design of structural member. Nevertheless, the loading of dismantli
Autor:
Si Young Kim, Sook Hee Hong, Sam Yong Kim, Chul Soo Kim, Sang Won Shin, Jin-Hyuk Choi, Young Seon Hong, Sang Young Roh, Chang Yeol Yim, Chang Hak Sohn, Hong Suk Song
Publikováno v:
Journal of Pain and Symptom Management. 41:93-103
In Korea, many health care professionals have shown increased concern about the management of cancer pain. Five years after a pain management guideline was distributed to Korean physicians, the Korean Society of Hospice and Palliative Care evaluated
Autor:
Sang We Kim, Byeong Bae Park, Heung Tae Kim, Sang Won Shin, Jong Seog Lee, Chang Hak Sohn, Jin Hyuck Choi, Myung-Ju Ahn, Se Hoon Park, Jin Hyung Kang, Keunchil Park, Ji Eun Uhm, Jin Seok Ahn, Jae Yong Cho, Jeeyun Lee, Hong Suk Song
Publikováno v:
Journal of Thoracic Oncology. 4:1136-1143
Background Erlotinib (Tarceva, OSI Pharmaceuticals, Melville, NY) is an oral, epidermal growth factor receptor tyrosine kinase inhibitor that has antitumor activity and good tolerability in non-small cell lung cancer (NSCLC). In particular, higher re
Autor:
Joo Seop Jung, Jong Gwang Kim, Gab Chul Kim, Myung Soo Hyun, Hong Suk Song, Ki-Young Kwon, Chang-Hak Sohn, Min Kyoung Kim, Kyung Hee Lee, Ho Young Chung, Young Rok Do, Yee Soo Chae, Won Sik Lee, Sang Kyun Sohn, Wansik Yu
Publikováno v:
Cancer Chemotherapy and Pharmacology. 64:355-360
The present study analyzed the polymorphisms of apoptosis-related genes and their impact on the response to chemotherapy and survival of patients with advanced gastric cancer. Fifty-seven patients with advanced gastric cancer treated with paclitaxel
Autor:
Sang Kyun Sohn, Hyeoung-Joon Kim, Jong Gwang Kim, Ho-Jin Shin, Goon Jae Cho, Eun Yup Lee, Yeo-Kyeoung Kim, Chang-Hak Sohn, Young Jin Choi, Je-Jung Lee, Deok-Hwan Yang, Won Sik Lee, Joo Seop Chung, Young Don Joo
Publikováno v:
Journal of Korean Medical Science
The objective of the current study was to investigate the treatment outcomes for the use of cyclophosphamide, adriamycin, vincristine, and prednisolone (CHOP) chemotherapy in adult patients with hemophagocytic lymphohistiocytosis (HLH). Seventeen HLH
Autor:
Jong Mu Sun, Jun Ho Ji, Sang Won Shin, In Sung Cho, Dae Seog Heo, Jung Hun Kang, Tak Yun, Keunchil Park, Sung-Bae Kim, Ji Chan Park, Chang Hak Sohn, Joung Soon Jang, Deok Won Hwang, Myung-Ju Ahn
Publikováno v:
European journal of cancer (Oxford, England : 1990). 48(17)
Background The purpose of this phase II study was to determine the efficacy and toxicity of cisplatin and weekly docetaxel combination chemotherapy as a first-line treatment in patients with recurrent or metastatic nasopharyngeal cancer. Patients and
Autor:
Young Suk Park, Chang-Hak Sohn, Keun Wook Lee, Hun-Mo Ryoo, Hong-Suk Song, Do-Youn Oh, Kyung Hee Lee, Jin Soo Kim, Hye Jin Kang, Yung-Jue Bang, Dae Young Zang, Bongseog Kim
Publikováno v:
Investigational new drugs. 30(3)
Background To confirm the efficacy and toxicity of Erlotinib in combination with Gemcitabine and Capecitabine when used as a first-line therapy in metastatic/recurrent pancreatic cancer (PC). Methods Locally advanced PC was excluded. Erlotinib was gi
Autor:
Hong Suk Song, Hee Sook Park, Hun Mo Ryoo, Joo Seop Chung, Kyung Hee Lee, Young Rok Do, Hyung Min Jin, Chang Hak Sohn, Soon Nam Lee, Hoon-Kyo Kim, Jun Suk Kim, Jong Youl Jin, Myung Soo Hyun, Dae Young Zang, Chang Yeol Yim, Ho-Yeong Lim, Jin-Mo Yang
Publikováno v:
Cancer research and treatment. 41(1)
Purpose Heptaplatin (Sunpla) is a cisplatin derivative. A phase IIb trial using heptaplatin resulted in a 34% response rate with mild nephrotoxicity. We conducted a randomized phase III trial of heptaplatin plus 5-FU compared with cisplatin plus 5-FU
Autor:
Hong Suk Song, Jin Seok Ahn, Chang Hak Sohn, Byeong-Bae Park, Chan Keum Park, Se Hoon Park, Keunchil Park, Jin Hyuck Choi, Jong Seog Lee, Pasi A. Jänne, Alison J. Holmes, Sang We Kim, Heung-Tae Kim, Chang-Seok Ki, Jin Hyung Kang, Jae Yong Cho, Myung-Ju Ahn, Sang Won Shin
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 14(12)
Purpose: This study investigated possible molecular predictors of outcome in Korean patients with advanced non-small cell lung cancer treated with erlotinib. Experimental Design: One hundred and twenty patients received erlotinib and were followed pr